ATLASBiofrontera (BFRI) earnings date: Nov 11, 2026
Biofrontera (BFRI) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026, before the open. Analysts expect EPS of -$0.33.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on BFRI
| Last price | $0.85 (-2.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.7% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Biofrontera stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Biofrontera reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Biofrontera. You can switch it off at any time.
Alert me before BFRI reportsFree to start. Creating an account takes under a minute.
Notify me when Biofrontera reports
Track BFRI free Add Biofrontera to a free ATLAS watchlist and see its next report date in one place.
BFRI earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.33 |
| Last report | Aug 13, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -66.4% |
| Average move around a report | ±4.9% (last 5) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
Biofrontera earnings history: last 5 reports
Biofrontera last reported on Aug 13, 2026: EPS of -$0.05 against an estimate of -$0.04 (-25.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.04 | -$0.05 | -25.0% | Miss | +4.0% |
| Jul 10, 2026 | $1.49 | $1.56 | +4.7% | Beat | -2.6% |
| May 14, 2026 | -$0.05 | -$0.41 | -720.0% | Miss | -16.7% |
| Mar 19, 2026 | $0.10 | $0.50 | +400.0% | Beat | +0.1% |
| Jan 27, 2026 | $2.20 | $2.38 | +8.2% | Beat | -1.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for BFRI
See the fair value, the probability range and the earnings history of Biofrontera on its ATLAS page.
Biofrontera (BFRI) stock analysisPlans from €3.99 a month.
Biofrontera earnings: frequently asked questions
When does Biofrontera (BFRI) report earnings?
Biofrontera is scheduled to report on Wednesday, November 11, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for BFRI?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.33 per share (USD). Estimates can change before the report.
How often does BFRI beat earnings estimates?
Of its last 5 reports with a recorded result, Biofrontera beat the EPS estimate 3 times; the average surprise was -66.4%. Past results do not predict the next one.
How much does BFRI move around earnings?
Over its last 5 reports the stock moved an average of 4.9% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Biofrontera beat earnings estimates last quarter?
Biofrontera last reported on Aug 13, 2026: EPS of -$0.05 against an estimate of -$0.04 (-25.0% surprise), a miss.
How much does BFRI usually move in a day?
On a normal trading day the ATLAS model puts BFRI’s one-day range at about ±4.7%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer